![](/images/graphics-bg.png)
Psoriasis and Respiratory Comorbidities: The Added Value of Fraction of Exhaled Nitric Oxide as a New Method to Detect, Evaluate, and Monitor Psoriatic Systemic Involvement and Therapeutic Efficacy
Joint Authors
Colombo, Delia
Santus, Pierachille
Rizzi, Maurizio
Airoldi, Andrea
Cristiano, Andrea
Conic, Rosalynn
Petrou, Stephen
Pigatto, Paolo Daniele Maria
Goldust, Mohamad
Damiani, Giovanni
Radovanovic, Dejan
Bragazzi, Nicola Luigi
Source
Issue
Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-10, 10 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2018-09-23
Country of Publication
Egypt
No. of Pages
10
Main Subjects
Abstract EN
Psoriasis is a chronic inflammatory systemic disease characterized by a wide range of comorbidities.
Respiratory comorbidities are currently poorly characterized and with discordant results.
The systemic state of inflammation caused by psoriasis acts de novo on respiratory tissues and amplifies preexisting inflammation from asthma or chronic obstructive pulmonary disease.
Because the lungs act as a gas exchanger between the internal and external environment, the impact of chronic psoriasis inflammation may be easily assessed through the analysis of exhaled breath.
The fraction of exhaled nitric oxide test (FeNO) is a potential noninvasive solution that can provide quantitative and qualitative indices of respiratory airway inflammation.
FeNO is routinely used to screen and manage asthmatic patients.
Recent pilot studies contain encouraging data that underscore its possible use with systemic inflammatory nonpulmonary diseases, such as psoriasis.
FeNO may therefore be a useful tool to evaluate underestimated airway inflammation and at the same time globally evaluate the impact of systemically antipsoriatic therapies.
American Psychological Association (APA)
Santus, Pierachille& Rizzi, Maurizio& Radovanovic, Dejan& Airoldi, Andrea& Cristiano, Andrea& Conic, Rosalynn…[et al.]. 2018. Psoriasis and Respiratory Comorbidities: The Added Value of Fraction of Exhaled Nitric Oxide as a New Method to Detect, Evaluate, and Monitor Psoriatic Systemic Involvement and Therapeutic Efficacy. BioMed Research International،Vol. 2018, no. 2018, pp.1-10.
https://search.emarefa.net/detail/BIM-1125663
Modern Language Association (MLA)
Santus, Pierachille…[et al.]. Psoriasis and Respiratory Comorbidities: The Added Value of Fraction of Exhaled Nitric Oxide as a New Method to Detect, Evaluate, and Monitor Psoriatic Systemic Involvement and Therapeutic Efficacy. BioMed Research International No. 2018 (2018), pp.1-10.
https://search.emarefa.net/detail/BIM-1125663
American Medical Association (AMA)
Santus, Pierachille& Rizzi, Maurizio& Radovanovic, Dejan& Airoldi, Andrea& Cristiano, Andrea& Conic, Rosalynn…[et al.]. Psoriasis and Respiratory Comorbidities: The Added Value of Fraction of Exhaled Nitric Oxide as a New Method to Detect, Evaluate, and Monitor Psoriatic Systemic Involvement and Therapeutic Efficacy. BioMed Research International. 2018. Vol. 2018, no. 2018, pp.1-10.
https://search.emarefa.net/detail/BIM-1125663
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1125663